Tenure-Track Investigator, Radiation Epidemiology Branch
The Radiation Epidemiology Branch (REB), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is recruiting a tenure-track investigator to develop an independent research program focused on the adverse health effects of treatment, including radiotherapy, in cancer survivors, and modifiers of survival after cancer diagnosis.
DCEG is one of the world’s most comprehensive cancer epidemiology research groups. Its distinguished epidemiologists, geneticists, and biostatisticians conduct population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. Within DCEG, REB’s broad-based research program has a three-fold research mission: to characterize and quantify the carcinogenic effects of radiation; to improve our understanding of molecular mechanisms of radiation carcinogenesis; and to address issues of public concern about radiation exposure. One focus of the program is quantifying risks among cancer survivors for developing adverse health effects of treatment, with particular emphasis on risks following radiotherapy. Areas of interest include quantification of the magnitude and shape of the radiation dose-response relationship following specific types of radiotherapy exposures and investigation of potential modifiers of radiation-related risks, including systemic therapies, genetic susceptibility, other patient-related factors, and other cancer risk factors. Investigations conducted by REB include both pediatric and adult cancer survivors and involve interdisciplinary approaches with the goal of improving the clinical care and quality of life of cancer survivors. These investigations provide critical data for assessing risks and benefits of current cancer treatment approaches and for guiding clinical recommendations for the long-term management of cancer survivors. REB investigators also are actively engaged in DCEG’s Cancer Survivorship Research Unit (CSRU), which promotes survivorship research across the entire Division. Learn more about REB research.
We are seeking a tenure-track investigator to develop an independent research program on adverse health effects of treatment, including radiotherapy, in cancer survivors. The successful candidate will have access to advanced computational resources, state-of-the-art genomics facilities, mentoring and other research support, including opportunities to build on existing REB studies as described on the branch website. Additional training to support development of an interdisciplinary research program that aligns with the REB and CSRU missions also will be provided based on the applicant’s background and future research goals. The applicant also will be supported in the development of collaborations across REB, CSRU, DCEG as well as the NCI/NIH more broadly.
Applicants must have a doctorate or equivalent qualification in epidemiology, medicine, genetics, or related field, relevant experience after the doctorate in cancer research, survivorship, and/or radiation epidemiology, and excellent computational skills. A strong record of publications demonstrating an ability to lead an independent research program and collaborate effectively is required. Candidates will be evaluated on evidence of specific accomplishments; creativity and novelty of scientific vision and alignment of that vision with REB and CSRU goals; sound analytic knowledge and skills; collaborative teamwork, especially across disciplines; productivity; evidence of effective and efficient project leadership; and effective oral and written scientific communication. Experience working in studies with molecular or genetic components would be advantageous. Candidates must be sufficiently experienced to function independently, both in the development of their own research program and in the mentoring and supervision of more junior scientists.
Appointees may be U.S. citizens, permanent U.S. residents, or non-residents of the U.S. with or eligible to obtain a valid employment-authorized visa. Salary is competitive and will be commensurate with the experience of the candidate. A recruitment or relocation bonus may be available, and relocation expenses may be paid. A full package of federal Civil Service benefits is available, including retirement, health and life insurance, long term care insurance, leave, and a Thrift Savings Plan (401K equivalent).
How to Apply
Interested individuals must submit applications at NIH SCSS (cancer.gov). Applications received by December 22, 2023 will be considered for a first round of interviews, but applications will be accepted until the position is filled. Interested candidates should submit the following materials:
- Cover letter, including career synopsis.
- Research statement that addresses the specific required research accomplishments and research interests. Please limit this statement to three pages total.
- A current curriculum vitae with complete bibliography with ORCID or similar metric for citation analysis.
- Three letters of reference.
You may contact Dr. Hannah Yang for more information about this vacancy.
DHHS, NIH, and NCI are Equal Opportunity Employers
Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization.
Standards of Conduct/Financial Disclosure
The National Institutes of Health inspires public confidence in our science by maintaining high ethical principles. NIH employees are subject to Federal government-wide regulations and statutes as well as agency-specific regulations described at NIH Ethics. We encourage you to review this information. The position is subject to a background investigation and requires the incumbent to complete a public financial disclosure report prior to the effective date of the appointment.
Applicants who have completed part or all of their education outside of the U.S. must have their foreign education evaluated by an accredited organization to ensure that the foreign education is equivalent to education received in accredited educational institutions in the United States. We will only accept the completed foreign education evaluation. Find more information on foreign education verification. Verification must be received prior to the effective date of the appointment.
NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis.